These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11474697)

  • 21. Slowing the progression of heart failure.
    Cohn JN
    Eur Heart J; 1996 Nov; 17(11):1609-11. PubMed ID: 8922902
    [No Abstract]   [Full Text] [Related]  

  • 22. [Beta blockers in severe heart failure. Prognosis improves already after a short time].
    MMW Fortschr Med; 2002 Apr; 144(15):62. PubMed ID: 12013032
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
    Costalunga A; Gavazzi A
    Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
    Packer M; Lukas MA; Tenero DM; Baidoo CA; Greenberg BH;
    Am J Cardiol; 2006 Oct; 98(7A):39L-45L. PubMed ID: 17023231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study in heart failure. Which beta blocker saves more life time?].
    MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
    [No Abstract]   [Full Text] [Related]  

  • 26. [Carvedilol and heart failure: new findings].
    Cosín Aguilar J
    Rev Esp Cardiol; 1996 Feb; 49(2):85-7. PubMed ID: 8948716
    [No Abstract]   [Full Text] [Related]  

  • 27. [Heart failure symptoms despite normal pump function. Beta blockers also improve diastole].
    MMW Fortschr Med; 2003 Jun; 145(26):58. PubMed ID: 12916341
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary results of COPERNICUS, a pivotal landmark study (Carvedilol Prospective Randomised Cumulative Survival Trial).
    Cardiovasc J S Afr; 2001; 12(1):57. PubMed ID: 11474691
    [No Abstract]   [Full Text] [Related]  

  • 30. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure.
    Fowler MB
    Am J Cardiol; 2004 May; 93(9A):35B-9B. PubMed ID: 15144935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac remodeling in coronary artery disease.
    Sharpe N
    Am J Cardiol; 2004 May; 93(9A):17B-20B. PubMed ID: 15144932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
    Dargie HJ
    Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Patient with heart failure. Beta blockage becomes mandatory].
    Einecke D
    MMW Fortschr Med; 2000 Sep; 142(36):14-6. PubMed ID: 11021061
    [No Abstract]   [Full Text] [Related]  

  • 35. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualising heart failure patients to beta-blocker therapy.
    Cardiovasc J S Afr; 2004; 15(2):88, 91. PubMed ID: 15148544
    [No Abstract]   [Full Text] [Related]  

  • 37. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE
    Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program.
    Gilbert EM
    Am J Cardiol; 2004 May; 93(9A):30B-4B. PubMed ID: 15144934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.